Skip to main content

2019 | OriginalPaper | Buchkapitel

Pre-operative Overall Survival Time Prediction for Glioblastoma Patients Using Deep Learning on Both Imaging Phenotype and Genotype

verfasst von : Zhenyu Tang, Yuyun Xu, Zhicheng Jiao, Junfeng Lu, Lei Jin, Abudumijiti Aibaidula, Jinsong Wu, Qian Wang, Han Zhang, Dinggang Shen

Erschienen in: Medical Image Computing and Computer Assisted Intervention – MICCAI 2019

Verlag: Springer International Publishing

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config
loading …

Abstract

Glioblastoma (GBM) is the most common and deadly malignant brain tumor with short yet varied overall survival (OS) time. Per request of personalized treatment, accurate pre-operative prognosis for GBM patients is highly desired. Currently, many machine learning-based studies have been conducted to predict OS time based on pre-operative multimodal MR images of brain tumor patients. However, tumor genotype, such as MGMT and IDH, which has been proven to have strong relationship with OS, is completely not considered in pre-operative prognosis as the genotype information is unavailable until craniotomy. In this paper, we propose a new deep learning based method for OS time prediction. It can derive genotype related features from pre-operative multimodal MR images of brain tumor patients to guide OS time prediction. Particularly, we propose a multi-task convolutional neural network (CNN) to accomplish tumor genotype and OS time prediction tasks. As the network can benefit from learning genotype related features toward genotype prediction, we verify upon a dataset of 120 GBM patients and conclude that the multi-task learning can effectively improve the accuracy of predicting OS time in personalized prognosis.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 390 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Maschinenbau + Werkstoffe




 

Jetzt Wissensvorsprung sichern!

Springer Professional "Wirtschaft"

Online-Abonnement

Mit Springer Professional "Wirtschaft" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 340 Zeitschriften

aus folgenden Fachgebieten:

  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Versicherung + Risiko




Jetzt Wissensvorsprung sichern!

Literatur
1.
Zurück zum Zitat Anil, R., Colen, R.R.: Imaging genomics in glioblastoma multiforme: a predictive tool for patients prognosis, survival, and outcome. Magn. Reson. Imaging Clin. 24(4), 731–740 (2016)CrossRef Anil, R., Colen, R.R.: Imaging genomics in glioblastoma multiforme: a predictive tool for patients prognosis, survival, and outcome. Magn. Reson. Imaging Clin. 24(4), 731–740 (2016)CrossRef
2.
Zurück zum Zitat Ostrom, Q.T., et al.: CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014. Neuro-Oncol. 19(suppl_5), v1–v88 (2017)MathSciNetCrossRef Ostrom, Q.T., et al.: CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014. Neuro-Oncol. 19(suppl_5), v1–v88 (2017)MathSciNetCrossRef
3.
Zurück zum Zitat Chow, D., et al.: Imaging genetic heterogeneity in glioblastoma and other glial tumors: review of current methods and future directions. Am. J. Roentgenol. 210(1), 30–38 (2018)CrossRef Chow, D., et al.: Imaging genetic heterogeneity in glioblastoma and other glial tumors: review of current methods and future directions. Am. J. Roentgenol. 210(1), 30–38 (2018)CrossRef
5.
Zurück zum Zitat Lefranc, F., et al.: Present and potential future issues in glioblastoma treatment. Expert Rev. Anticancer Ther. 6(5), 719–732 (2006)CrossRef Lefranc, F., et al.: Present and potential future issues in glioblastoma treatment. Expert Rev. Anticancer Ther. 6(5), 719–732 (2006)CrossRef
6.
Zurück zum Zitat Sottoriva, A., et al.: Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics. Proc. Natl. Acad. Sci. 110(10), 4009–4014 (2013)CrossRef Sottoriva, A., et al.: Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics. Proc. Natl. Acad. Sci. 110(10), 4009–4014 (2013)CrossRef
7.
Zurück zum Zitat Nie, D., Zhang, H., Adeli, E., Liu, L., Shen, D.: 3D deep learning for multi-modal imaging-guided survival time prediction of brain tumor patients. In: Ourselin, S., Joskowicz, L., Sabuncu, M.R., Unal, G., Wells, W. (eds.) MICCAI 2016. LNCS, vol. 9901, pp. 212–220. Springer, Cham (2016). https://doi.org/10.1007/978-3-319-46723-8_25CrossRef Nie, D., Zhang, H., Adeli, E., Liu, L., Shen, D.: 3D deep learning for multi-modal imaging-guided survival time prediction of brain tumor patients. In: Ourselin, S., Joskowicz, L., Sabuncu, M.R., Unal, G., Wells, W. (eds.) MICCAI 2016. LNCS, vol. 9901, pp. 212–220. Springer, Cham (2016). https://​doi.​org/​10.​1007/​978-3-319-46723-8_​25CrossRef
8.
Zurück zum Zitat Chang, P., et al.: Deep learning for prediction of survival in IDH wild-type gliomas. J. Neurol. Sci. 381, 172–173 (2017)CrossRef Chang, P., et al.: Deep learning for prediction of survival in IDH wild-type gliomas. J. Neurol. Sci. 381, 172–173 (2017)CrossRef
9.
Zurück zum Zitat Weller, M., et al.: MGMT promoter methylation in malignant gliomas: ready for personalized medicine? Nat. Rev. Neurol. 6(1), 39 (2010)CrossRef Weller, M., et al.: MGMT promoter methylation in malignant gliomas: ready for personalized medicine? Nat. Rev. Neurol. 6(1), 39 (2010)CrossRef
10.
Zurück zum Zitat Czapski, B., et al.: Clinical and immunological correlates of long term survival in glioblastoma. Contemp. Oncol. 22(1A), 81 (2018) Czapski, B., et al.: Clinical and immunological correlates of long term survival in glioblastoma. Contemp. Oncol. 22(1A), 81 (2018)
11.
Zurück zum Zitat Hill, C., Hunter, S.B., Brat, D.J.: Genetic markers in glioblastoma: prognostic significance and future therapeutic implications. Adv. Anat. Pathol. 10(4), 212–217 (2003)CrossRef Hill, C., Hunter, S.B., Brat, D.J.: Genetic markers in glioblastoma: prognostic significance and future therapeutic implications. Adv. Anat. Pathol. 10(4), 212–217 (2003)CrossRef
12.
Zurück zum Zitat Lee, Y., et al.: The frequency and prognostic effect of TERT promoter mutation in diffuse gliomas. Acta Neuropathol. Commun. 5(1), 62 (2017)CrossRef Lee, Y., et al.: The frequency and prognostic effect of TERT promoter mutation in diffuse gliomas. Acta Neuropathol. Commun. 5(1), 62 (2017)CrossRef
13.
Zurück zum Zitat van Griethuysen, J.J., et al.: Computational radiomics system to decode the radiographic phenotype. Cancer Res. 77(21), e104–e107 (2017)CrossRef van Griethuysen, J.J., et al.: Computational radiomics system to decode the radiographic phenotype. Cancer Res. 77(21), e104–e107 (2017)CrossRef
14.
Zurück zum Zitat Liu, J., Chen, J., Ye, J.: Large-scale sparse logistic regression. In: Proceedings of the 15th ACM SIGKDD International Conference on Knowledge Discovery and Data Mining. ACM (2009) Liu, J., Chen, J., Ye, J.: Large-scale sparse logistic regression. In: Proceedings of the 15th ACM SIGKDD International Conference on Knowledge Discovery and Data Mining. ACM (2009)
15.
Zurück zum Zitat Woolson, R.: Wilcoxon signed-rank test. Wiley Encyclopedia of Clinical Trials, pp. 1–3 (2007) Woolson, R.: Wilcoxon signed-rank test. Wiley Encyclopedia of Clinical Trials, pp. 1–3 (2007)
16.
Zurück zum Zitat Kaplan, E.L., Meier, P.: Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53(282), 457–481 (1958)MathSciNetCrossRef Kaplan, E.L., Meier, P.: Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53(282), 457–481 (1958)MathSciNetCrossRef
17.
Zurück zum Zitat Mantel, N.: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother. Rep. 50, 163–170 (1966) Mantel, N.: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother. Rep. 50, 163–170 (1966)
Metadaten
Titel
Pre-operative Overall Survival Time Prediction for Glioblastoma Patients Using Deep Learning on Both Imaging Phenotype and Genotype
verfasst von
Zhenyu Tang
Yuyun Xu
Zhicheng Jiao
Junfeng Lu
Lei Jin
Abudumijiti Aibaidula
Jinsong Wu
Qian Wang
Han Zhang
Dinggang Shen
Copyright-Jahr
2019
DOI
https://doi.org/10.1007/978-3-030-32239-7_46

Premium Partner